Atrys Health (BME: ATRY), founded in 2015, is a Spanish multinational that provides precision medical prediction, prevention, diagnosis and treatment services. Pioneer in the fields of telemedicine and state-of-the-art radiation therapy.
The company integrates a team of more than 2000 professionals in Spain, Portugal, Switzerland and Latin America.
Atrys structures its prevention and precision activity around five business units: telemedicine, oncology, pathology, prevention and big data. Through these, the company carries out conventional and advanced radiotherapy treatments, performs diagnostic tests in its own network of laboratories, analyzes radiology, cardiology, ophthalmology and dermatology tests electronically, and provides smart and big data to the health sector.
Interview with Isabel LozanoCEO of Atrys Health
Entrevista a Santiago de TorresPresidente ejecutivo de Atrys Health
BME welcomes Atrys Health as it moves from BME Growth to the stock exchange
BME da la bienvenida a Atrys Health en su paso de BME Growth a la Bolsa
Entrevista con Santiago de TorresPresidente de Atrys Health
Atrys HealthDiscovery MeetingForo Medcap 2021
Atrys HealthResumen Discovery MeetingForo Medcap 2019
Atrys Health Resumen Discovery MeetingForo Medcap 2017
Santiago de Torres, PresidenteAtrys Health
To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.
The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.